Immediate Impact
64 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Oesophageal cancer
2024 Standout
Works of Francesca Pucci being referenced
CAPTEM or FOLFIRI as second-line therapy in neuroendocrine carcinomas and exploratory analysis of predictive role of PET imaging and biological markers (SENECA study)
2018
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma
2003
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Francesca Pucci | 239 | 119 | 96 | 25 | 317 | |
| Wen‐Yih Liang | 200 | 79 | 151 | 17 | 350 | |
| Lauren M. Postlewait | 279 | 96 | 106 | 18 | 342 | |
| Laura Antolino | 138 | 155 | 171 | 31 | 318 | |
| Lauren M. Postlewait | 263 | 77 | 104 | 38 | 304 | |
| Tetsufumi Kojima | 107 | 106 | 176 | 22 | 318 | |
| Richard Knoop | 136 | 53 | 77 | 26 | 295 | |
| Katsumi Kurihara | 176 | 117 | 192 | 19 | 338 | |
| J-P. Metges | 201 | 195 | 160 | 20 | 304 | |
| Silvana Leo | 248 | 87 | 68 | 17 | 354 | |
| Carrie Luu | 167 | 86 | 94 | 32 | 283 |
All Works
Loading papers...